veloped by German surgeons, Augustin Betz and Rainer Baumgart, the minimally-invasive surgery requires the bone of the leg to be cut before remote-controlled motorized nails are implanted. Through radio signals from an external transmitter, the nail expands about 1mm a day and allows bone tissue to grow around a rod inserted insider the hollow interior of the bone (marrow).
After being lengthened, the bone is then allowed to solidify. The surgery takes three to four hours with a week-long hospital stay and another nine months before the patient can walk again. The rod is removed after two years.
Prof Sarbjit asserts, "Besides being less traumatic, Fitbone spares the patient the inconvenience of any external scaffolding. Moreover, infection and scarring is minimal and risk of misalignment due to movement of the frame is eliminated."
Although originally intended for medical use, it has now become increasingly popular in cosmetic leg lengthening. Prof Sarbjit reports that 60 per cent of the Fitbone surgeries he has carried out were on individuals wanting to be taller or professional models who desire the added height to capture lucrative runway assignments.
Whether it is for medical or cosmetic reasons, Prof Sarbjit would only perform Fitbone surgery after making sure that his patients fully understand the risks involved. For cosmetic limb lengthening, he recommends it for those with constitutional short stature; meaning 165cm or below for males, and 155cm or below for females.
"It's important in these cases, not to over-lengthen the limbs. It must be aesthetically acceptable. The maximum I have increased a person's leg length is by 11 cm, using four rods, above and below the knee. My shortest patient was a 152 cm tall male,&q
'/>"/>
Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia2.
Healthy Travel Media Launches Second Edition of Patients Beyond Borders Singapore Edition3.
Singapore Caters to Middle East Medical Travelers with Arabic Version of Patients Beyond Borders-Singapore Edition4.
Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers5.
Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore6.
Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion7.
Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research8.
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.9.
Marian Koshland Science Museum forms partnership with Science Center Singapore10.
Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.11.
Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore